Cargando…
Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing–Remitting and Primary Progressive Multiple Sclerosis
Background: Multiple sclerosis (MS) is a chronic immunemediated disease of the central nervous system with a highly variable clinical presentation and disease progression. In this study, we investigate the metabolomics profile of patients affected by relapsing–remitting MS (RRMS)and primary progress...
Autores principales: | Murgia, Federica, Lorefice, Lorena, Poddighe, Simone, Fenu, Giuseppe, Secci, Maria Antonietta, Marrosu, Maria Giovanna, Cocco, Eleonora, Atzori, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141510/ https://www.ncbi.nlm.nih.gov/pubmed/32245176 http://dx.doi.org/10.3390/jcm9030863 |
Ejemplares similares
-
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis
por: Cocco, Eleonora, et al.
Publicado: (2015) -
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
por: Cocco, Eleonora, et al.
Publicado: (2015) -
Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis
por: Lorefice, Lorena, et al.
Publicado: (2023) -
Metabolomic Changes in Patients Affected by Multiple Sclerosis and Treated with Fingolimod
por: Murgia, Federica, et al.
Publicado: (2023) -
Menopausal transition in multiple sclerosis: relationship with disease activity and brain volume measurements
por: Lorefice, Lorena, et al.
Publicado: (2023)